Quick Ratio of Revance Therapeutics, Inc. from 31 Mar 2021 to 30 Sep 2024

Taxonomy & unit
ratio: %
Description
The acid-test ratio, also called the quick ratio, is a metric used to see if a company is positioned to sell assets within 90 days to meet immediate expenses.
Summary
Revance Therapeutics, Inc. quarterly Quick Ratio in % history and change rate from 31 Mar 2021 to 30 Sep 2024.
  • Revance Therapeutics, Inc. Quick Ratio for the quarter ending 30 Sep 2024 was 75%, a 84% increase year-over-year.
Quick Ratio, Quarterly (%)
Quick Ratio, YoY Quarterly Change (%)

Revance Therapeutics, Inc. Quarterly Quick Ratio (%)

Period Value YoY Chg Change % Date
Q3 2024 75% +34% +84% 30 Sep 2024
Q2 2024 63% +31% +95% 30 Jun 2024
Q1 2024 56% +31% +123% 31 Mar 2024
Q4 2023 48% +28% +138% 31 Dec 2023
Q3 2023 41% +23% +130% 30 Sep 2023
Q2 2023 32% +16% +104% 30 Jun 2023
Q1 2023 25% +11% +83% 31 Mar 2023
Q4 2022 20% +7% +56% 31 Dec 2022
Q3 2022 18% +6% +57% 30 Sep 2022
Q2 2022 16% +7% +80% 30 Jun 2022
Q1 2022 14% +6% +89% 31 Mar 2022
Q4 2021 13% 31 Dec 2021
Q3 2021 11% 30 Sep 2021
Q2 2021 9% 30 Jun 2021
Q1 2021 7% 31 Mar 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.